SpaceX reclaims $135 IPO price in premarket trade Monday
SpaceX’s stock (SPCX) rose about 2.3% in Monday premarket to around $136.20, reclaiming its $135 IPO price. The article cites an Argus upgrade to Buy with a $160 target, limited insider selling after Aug. 6 unlocks, and SpaceX and Tesla’s planned $16.8B “Terafab” chip complex in Texas. It also notes Q2 2026 revenue of $7.814B and higher capex.
How this was made
The 30-second read
Why it matters
SPCX is attempting to consolidate above its $135 IPO reference level as investors digest earnings details (strong revenue growth but heavy AI capex), an analyst upgrade, and a major announced semiconductor fabrication complex.
Market read
Traders get a near-term setup for SPCX around the IPO price level, with concrete catalysts (upgrade, insider-selling outcome, Terafab) and explicit volatility risks (share unlocks, peer earnings, macro inflation).
What to watch
Upcoming lockup tranches through Dec 8 and the after-hours earnings from RKLB and ASTS could quickly change the risk premium, making any early strength fragile.
Background
The article frames SPCX’s post-IPO trading as a volatile, AI-compute-driven story that sold off after Aug 4 results, then began recovering into Monday.
Ticker impact
SpaceX shares are up about 2.3% premarket to $136.20, reclaiming the $135 IPO price after the Aug 4 earnings-driven dip.
Bias to continued strength early Monday, with elevated intraday swings as supply from unlocked shares and upcoming peer earnings can reverse sentiment.
The article ties the move to specific, time-relevant drivers: an Argus upgrade with a $160 target, reduced-than-feared insider selling, and a newly announced $16.8B Terafab semiconductor complex in Texas, while also warning that ongoing unlock tranches through Dec 8 likely keep volatility elevated.
Market effects
Space/AI compute narrative remains a key driver for high-multiple space names, so peer earnings (RKLB, ASTS) may spill over into SPCX sentiment.
Texas semiconductor buildout narrative could reinforce investor focus on AI infrastructure capex themes.
Macro risk from the week’s inflation data could pressure high-multiple tech-like growth valuations, affecting SPCX’s ability to sustain gains.
Counterpoint
The stock’s rebound may be more about supply dynamics and sentiment than fundamentals, since AI-related capex surged and could pressure near-term free cash flow.
Key entities
- companySpaceX
Subject of the article, with shares reclaiming the $135 IPO price in premarket trade and catalysts tied to earnings, analyst upgrades, and the Terafab announcement.
- projectTerafab semiconductor fabrication complex
$16.8B facility in Grimes County, Texas, positioned as AI compute infrastructure with potential multi-phase investment.
- analyst_firmArgus Research
Upgraded SPCX to Buy and set a $160 price target, supporting the premarket bid.
- research_firmVanda Research
Reported net retail buying of $22.7M in the first hour after the post-earnings sell-off day.
- market_commentatorActivTrades (Carolane de Palmas)
Warned that unlocked shares likely keep volatility elevated through scheduled tranches into December.




